3月28日，老牌药企石药集团(01093)发布年度报告，公司2024年实现营收290.09亿元，同比减7.8%；归母净利润43.28亿元，同比减少26.3%。值得注意的是，这是石药集团近10年来首次营收净利双双下滑。具体来看，该公司核心业务板块成药制剂全年营收达237.36亿元，较上年同期下降7.4%。其中抗肿瘤板块受市场环境影响最为显著，同比锐减28.3%，仅为44.00亿元。此外，原料产品、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.